N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index

Clinical Biochemistry

Volumn 42, Issue 15, 2009, Pages 1500-1503

  Sezen, Yusuf ^a   Baş, Memduh ^a   Demirbag, Recep ^a   Yildiz, Ali ^a   Celik, Hakim ^a   Aksoy, Sahin ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Left ventricular mass index; Metabolic syndrome; N Terminal pro brain natriureti dotless c peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HEART LEFT VENTRICLE MASS; HUMAN; LIPID ANALYSIS; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HEART VENTRICLES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 70249108773     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.07.007     Document Type: Article

References (23)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Grundy S.M. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83 (1999) 25F-29F
3. Nakao K., Ogawa Y., Suga S., and Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I. Natriuretic peptides. J. Hypertens. 10 (1992) 907-912
4. Downie P.F., Talwar S., Squire I.B., Davies J.E., Barnett D.B., and Ng L.L. Assessment of the stability of N-terminal pro-brain natriuretic peptide in-vitro: implications for assessment of left ventricular dysfunction. Clin. Sci. 97 (1999) 255-258
5. Ceyhan C., Unal S., Yenisey C., Tekten T., and Ceyhan F.B. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients. Int. J. Cardiovasc. Imaging 24 (2008) 253-259
6. Talwar S., Siebenhofer A., and Williams B Ng L. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart 83 (2000) 278-282
7. Chinali M., de Simone G., Roman M.J., Best L.G., Lee E.T., Russell M., et al. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J. Am. Coll. Cardiol. 52 (2008) 932-938
8. Olsen M.H., Hansen T.W., Christensen M.K., et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46 (2005) 660-666
9. Buckley M.G., Markandu N.D., Miller M.A., Sagnella G.A., and MacGregor G.A. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J. Hum. Hypertens. 7 (1993) 245-250
10. Yano Y., Katsuki A., Gabazza E.C., et al. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J. Clin. Endocrinol. Metab. 84 (1999) 2353-2356
11. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
12. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
13. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
14. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proarterial natriuretic peptide. Circulation 93 (1996) 1963-1969
15. Wang T.J., Larson M.G., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
16. Khush K.K., Gerber I.L., McKeown B., et al. Obese patients have lower B-type and atrial natriuretic peptide levels compared with nonobese. Congest. Heart Fail. 12 (2006) 85-90
17. Crandall D.L., Ferraro G.D., and Cervoni P. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc. Soc. Exp. Biol. Med. 191 (1989) 352-356
18. Messerli F.H., Ventura H.O., Reisin E., Dreslinski G.R., Dunn F.G., and MacPhee A.A. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 66 (1982) 55-60
19. Yasumoto K., Takata M., Ueno H., Tomita S., Tomoda F., and Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am. J. Hypertens. 12 (1999) 921-924
20. Alibay Y., Beauchet A., El Mahmoud R., et al. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed. Pharmacother. 59 (2005) 20-24
21. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur. Heart J. 26 (2005) 2269-2276
22. Wang T.J., Larson M.G., Levy D., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am. J. Cardiol. 90 (2002) 254-258
23. Dessi-Fulgheri P., Sarzani R., Tamburrini P., et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J. Hypertens. 15 (1997) 1695-1699